We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
126
Humana
HUM
$46.4B
$28.6M 0.19%
55,755
+5,253
+10% +$2.76M
C icon
127
Citigroup
C
$221B
$28.4M 0.19%
627,881
+308,831
+97% +$14M
MMM icon
128
3M
MMM
$93.7B
$27.9M 0.19%
277,844
-27,006
-9% -$2.75M
OLED icon
129
Universal Display
OLED
$3.85B
$27.8M 0.19%
257,498
+59
+0% +$6.19K
GWW icon
130
W.W. Grainger
GWW
$65.6B
$27.8M 0.19%
49,914
+1,526
+3% +$861K
XYL icon
131
Xylem
XYL
$29.6B
$27.1M 0.18%
245,408
-41,219
-14% -$4.32M
CHD icon
132
Church & Dwight Co
CHD
$23.9B
$27.1M 0.18%
335,895
-3,619
-1% -$278K
HLT icon
133
Hilton Worldwide
HLT
$73.6B
$26.6M 0.18%
210,708
+33,689
+19% +$4.44M
BRKR icon
134
Bruker
BRKR
$9.43B
$26.5M 0.18%
388,186
-60,000
-13% -$3.81M
CPNG icon
135
Coupang
CPNG
$27.8B
$26.5M 0.18%
1,800,364
+496,214
+38% +$8.76M
CSX icon
136
CSX Corp
CSX
$95.1B
$26.4M 0.18%
853,121
-34,765
-4% -$1.05M
ES icon
137
Eversource Energy
ES
$28.5B
$25.7M 0.17%
306,950
+16,820
+6% +$1.33M
PGR icon
138
Progressive
PGR
$129B
$25.5M 0.17%
196,829
+103,227
+110% +$13.1M
CTAS icon
139
Cintas
CTAS
$86.3B
$25.3M 0.17%
224,076
+42,684
+24% +$4.62M
DG icon
140
Dollar General
DG
$27.8B
$25.3M 0.17%
102,615
+36,852
+56% +$9.11M
GIS icon
141
General Mills
GIS
$20.1B
$25.2M 0.17%
300,786
-4,940
-2% -$402K
DFS
142
DELISTED
Discover Financial Services
DFS
$25M 0.17%
255,971
+13,547
+6% +$1.36M
ICE icon
143
Intercontinental Exchange
ICE
$86.4B
$25M 0.17%
243,474
-12,438
-5% -$1.24M
KEYS icon
144
Keysight
KEYS
$51.7B
$24.8M 0.17%
145,225
-47,678
-25% -$8.13M
EA icon
145
Electronic Arts
EA
$52.4B
$24.7M 0.17%
202,292
+1,139
+0.6% +$143K
RSG icon
146
Republic Services
RSG
$67B
$24.7M 0.17%
191,367
+166,700
+676% +$22.2M
ISEE
147
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$24.3M 0.16%
1,135,832
+533,000
+88% +$11.4M
KDNY
148
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$24.3M 0.16%
926,155
+55,000
+6% +$1.22M
TRI icon
149
Thomson Reuters
TRI
$45.5B
$24.2M 0.16%
201,641
+655
+0.3% +$75.5K
URI icon
150
United Rentals
URI
$68.4B
$23.7M 0.16%
66,657
+22,136
+50% +$7.27M

Similar funds

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.